PDE12

phosphodiesterase 12

Basic information

Region (hg38): 3:57556274-57656480

Links

ENSG00000174840NCBI:201626OMIM:616519HGNC:25386Uniprot:Q6L8Q7AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PDE12 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PDE12 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
32
clinvar
1
clinvar
33
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 32 1 0

Variants in PDE12

This is a list of pathogenic ClinVar variants found in the PDE12 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
3-57556410-C-T not specified Uncertain significance (Jun 05, 2023)2515191
3-57556480-C-T not specified Uncertain significance (Oct 29, 2021)2258317
3-57556506-G-C not specified Uncertain significance (May 08, 2024)3305344
3-57556561-A-G not specified Uncertain significance (Jan 17, 2024)3210628
3-57556566-A-G not specified Uncertain significance (May 24, 2023)2551357
3-57556585-A-C not specified Uncertain significance (Nov 30, 2022)2329886
3-57556614-G-A not specified Uncertain significance (Feb 14, 2024)3210629
3-57556621-A-G not specified Uncertain significance (Apr 26, 2023)2568782
3-57556632-G-A not specified Uncertain significance (Feb 27, 2024)3210630
3-57556660-A-G not specified Uncertain significance (Feb 01, 2023)2480256
3-57556758-T-G not specified Uncertain significance (Dec 20, 2023)3210631
3-57556761-C-G not specified Uncertain significance (Nov 02, 2023)3210632
3-57556878-C-G not specified Uncertain significance (Feb 27, 2024)3210633
3-57556882-A-G not specified Uncertain significance (Dec 03, 2021)2264630
3-57556894-A-G not specified Uncertain significance (Aug 11, 2022)3210634
3-57557083-A-G not specified Uncertain significance (Feb 28, 2024)3210635
3-57557107-G-C not specified Uncertain significance (Jan 31, 2024)3210636
3-57557139-G-A not specified Likely benign (Dec 27, 2023)3210637
3-57557212-C-A not specified Uncertain significance (Mar 16, 2022)2215498
3-57557312-G-T not specified Uncertain significance (Sep 16, 2021)2207897
3-57557343-G-C not specified Uncertain significance (May 08, 2023)2545142
3-57557374-A-G not specified Uncertain significance (Nov 10, 2021)2241586
3-57557464-T-G not specified Uncertain significance (May 09, 2022)2357697
3-57557556-C-T not specified Uncertain significance (Feb 06, 2024)3210623
3-57557590-C-T not specified Uncertain significance (Feb 27, 2024)3210624

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PDE12protein_codingprotein_codingENST00000311180 310569
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.04440.9551257220261257480.000103
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.402683400.7870.00001593947
Missense in Polyphen5171.4910.71338837
Synonymous0.8181301420.9130.000006961268
Loss of Function2.87619.80.3039.02e-7240

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002520.000242
Ashkenazi Jewish0.0001020.0000992
East Asian0.00005440.0000544
Finnish0.00004620.0000462
European (Non-Finnish)0.0001330.000132
Middle Eastern0.00005440.0000544
South Asian0.00009800.0000980
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Enzyme that cleaves 2',5'-phosphodiester bond linking adenosines of the 5'-triphosphorylated oligoadenylates, triphosphorylated oligoadenylates referred as 2-5A modulates the 2-5A system. This enzyme degraded triphosphorylated 2-5A to produce AMP and ATP. Also cleaves 3',5'-phosphodiester bond of oligoadenylates. Plays a role as a negative regulator of the The 2-5A system that is one of the major pathways for antiviral and antitumor functions induced by interferons (IFNs). Suppression of this enzyme induces reduction of viral replication in Hela cells, thus counteracting the antiviral pathway probably by inhibiting the 2-5A system. {ECO:0000269|PubMed:15231837, ECO:0000269|PubMed:21245038, ECO:0000269|PubMed:21666256, ECO:0000269|PubMed:22285541}.;
Pathway
Phosphodiesterases in neuronal function (Consensus)

Recessive Scores

pRec
0.109

Intolerance Scores

loftool
0.403
rvis_EVS
-0.18
rvis_percentile_EVS
40.36

Haploinsufficiency Scores

pHI
0.0844
hipred
N
hipred_score
0.463
ghis
0.644

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.850

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Pde12
Phenotype
mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);

Gene ontology

Biological process
nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;mitochondrial mRNA catabolic process;mRNA processing;cellular response to interferon-alpha;regulation of mitochondrial mRNA stability;positive regulation of viral genome replication;defense response to virus;negative regulation of cell death;cellular response to interferon-gamma;cellular response to dsRNA;nucleic acid phosphodiester bond hydrolysis;negative regulation of oxidative phosphorylation;RNA phosphodiester bond hydrolysis, exonucleolytic
Cellular component
mitochondrial matrix;cytosol
Molecular function
3'-5'-exoribonuclease activity;exonuclease activity;poly(A)-specific ribonuclease activity;oligoribonucleotidase activity;metal ion binding